N° 4 Centaury
Food supplement declared in France, declaration No 2017-5-299, decision dated 8 May 2017
N° 4 Centaury (Herba-elixir) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Centaurium erythraea 0.00125 ml per day. None of the rules we check flags an issue with its declared composition.
- Brand
- Herba-elixir
- Food business operator placing the product on the market
- LEMON PHARMA FRANCE SARL
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Dropper
- Daily dose
- 6 gouttes
- Directions for use
- verser 3 goutes dans un verre d'eau, 2 fois par jour
- Intended populations
- People over 60, Men, Women
- Not recommended (according to the manufacturer)
- Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year)
Declaration 270259, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Centaurium erythraea Rafn | Flower | Aqueous macerate | 0.00125 ml |
Other ingredients
Cognac
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Brand : Herba-elixir
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “N° 4 Centaury (Herba-elixir): composition and regulation”, https://compoatlas.com/en/supplements/products/270259-n-4-centaury, updated 15 November 2026.